Search results for "ESBL"

showing 10 items of 34 documents

Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and foo…

2021

Abstract Objectives To assess the extent to which food items are a source of extended-spectrum β-lactamase (ESBL) -producing Escherichia coli (ESBL-Ec) and ESBL-producing Klebsiella pneumoniae (ESBL-Kp) for humans in five European cities. Methods We sampled 122 human polluted (hp)-environments (sewers and polluted rivers, as a proxy of human contamination) and 714 food items in Besancon (France), Geneva (Switzerland), Sevilla (Spain), Tubingen (Germany) and Utrecht (The Netherlands). A total of 254 ESBL-Ec and 39 ESBL-Kp isolates were cultured. All genomes were fully sequenced to compare their sequence types (ST) and core genomes, along with the distribution of blaESBL genes and their genet…

Microbiology (medical)Veterinary medicineKlebsiella pneumoniaeEscherichia coli K. pneumoniae ESBL food environmentBiologyEnvironmentPolluted environmentmedicine.disease_causebeta-LactamasesK. pneumoniae03 medical and health sciencesFood chainPlasmidData sequencesExtended-spectrum β-lactamasemedicinepolycyclic compoundsEscherichia coliHumansEscherichia coliEscherichia coli Infections030304 developmental biologyddc:6160303 health sciences030306 microbiologyK pneumoniaeGeneral MedicineSequence typesbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycoses3. Good healthAnti-Bacterial AgentsKlebsiella InfectionsKlebsiella pneumoniaeInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyESBLFoodbacteria[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyPlasmids
researchProduct

Correction: Mbehang Nguema, P.P., et al. Characterization of ESBL-Producing Enterobacteria from Fruit Bats in an Unprotected Area of Makokou, Gabon. …

2020

In Gabon, terrestrial mammals of protected areas have been identified as a possible source of antibiotic-resistant bacteria. Some studies on antibiotic resistance in bats have already been carried out. The main goal of our study was to detect extended-spectrum beta-lactamases (ESBLs) that are produced by enterobacteria from bats in the Makokou region in Gabon. Sixty-eight fecal samples were obtained from 68 bats caught in the forests located 1 km from the little town of Makokou. After culture and isolation, 66 Gram-negative bacterial colonies were obtained. The double-disk diffusion test confirmed the presence of ESBLs in six (20.69%) Escherichia coli isolates, four (13.79%) Klebsiella pneu…

Microbiology (medical)reservoirMicroorganismEsbl productionbatsCorrectionmultiresistanceBiologybiochemical phenomena metabolism and nutritionbacterial infections and mycosesMicrobiologyArticleMicrobiologyn/alcsh:Biology (General)ESBLVirologyGram-negative bacteriapolycyclic compoundsbacterialcsh:QH301-705.5Microorganisms
researchProduct

Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicill…

2020

Background: Antimicrobial resistance (AMR) thwarts the curative power of drugs and is a present-time global problem. We present data on antimicrobial susceptibility and resistance determinants of bacteria the WHO has highlighted as being key antimicrobial resistance concerns in Africa, to strengthen knowledge of AMR patterns in the region. Methods: Blood, stool, and urine specimens of febrile patients, aged between ≥ 30 days and ≤ 15 years and hospitalized in Burkina Faso, Gabon, Ghana, and Tanzania were cultured from November 2013 to March 2017 (Patients > 15 years were included in Tanzania). Antimicrobial susceptibility testing was performed for all Enterobacterales and Staphylococcus aur…

Microbiology (medical)sub-Saharan AfricaSalmonellaextended-spectrum beta-lactamase-(ESBL)Klebsiella pneumoniaemedicine.medical_treatmentlcsh:QR1-502Biologymethicillin-resistant Staphylococcus aureusmedicine.disease_causeMicrobiologylcsh:MicrobiologyMicrobiology03 medical and health sciencesAntibiotic resistanceEnterobacteralesparasitic diseasesmedicineantimicrobial resistanceOriginal Research030304 developmental biologyfever0303 health sciences030306 microbiologySalmonella entericabiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesMethicillin-resistant Staphylococcus aureusStaphylococcus aureusSalmonella entericaBeta-lactamaseMultilocus sequence typingFrontiers in microbiology
researchProduct

Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapene…

2020

Background: Experience in real clinical practice with ceftazidime-avibactam for the treatment of serious infections due to gram&minus

Nosocomial pneumonia0301 basic medicineMicrobiology (medical)medicine.medical_specialtymedicine.drug_classmedicine.medical_treatment030106 microbiologyAntibioticscarbapenem-sparing regimenBiologymedicine.disease_causeBiochemistryMicrobiologyArticleCarbapenem-sparing regimen; Ceftazidime-avibactam; ESBL-producing Enterobacterales; Nosocomial pneumonia; Pseudomonas aeruginosa03 medical and health sciences0302 clinical medicineESBL-producing EnterobacteralesCarbapenem-sparing regimenInternal medicinemedicinePharmacology (medical)030212 general & internal medicineRenal replacement therapyGeneral Pharmacology Toxicology and PharmaceuticsRisk factorAdverse effectESBL-producing Enterobacterales; Pseudomonas aeruginosa; carbapenem-sparing regimen; ceftazidime-avibactam; nosocomial pneumoniaCeftazidime-avibactamPseudomonas aeruginosaceftazidime-avibactamnosocomial pneumonialcsh:RM1-950medicine.diseaseCeftazidime/avibactamPneumonialcsh:Therapeutics. PharmacologyInfectious DiseasesEndocrinologyBacteremiaPseudomonas aeruginosaESBL-producing Enterobacteralemedicine.drugAntibiotics
researchProduct

Klebsiella pneumoniae rezistences noteikšana pret beta-laktāmu grupas antibakteriālajiem līdzekļiem

2018

Pret β-laktāmiem rezistentā K.pneumoniae izraisa nozokomiālās infekcijas, kuras nepakļaujas terapijai, pagarina slimošanas laiku, palielina finansiālo slogu un nāves risku, kā arī rada problēmas efektīvā antibakteriālās terapijas izvēlē nākotnē. Darba mērķis ir apkopot un analizēt datus par K.pneumoniae rezistences izmaiņām 3 gadu periodā. Jutība pret β-laktāma, aminoglikozīdu un hinolonu grupas antibiotikām tika noteikta, izmantojot disku difūzijas testu un E-testu. Karbapenemāzes producējošos celmus noteica ar Hodge testu, ESBL – ar dubultdisku metodi. Izolēti 588 K.pneumoniae celmi ar prevalenci 2017.gadā (5,8%). 10,71% no izolātiem bija ESBL producētāji. Rezultāti liecina, ka 2015. un 2…

PCRESBLK.pneumoniaeβ-laktāmiFarmācijarezistence
researchProduct

An international perspective on hospitalized patients with viral community-acquired pneumonia

2019

Background Who should be tested for viruses in patients with community acquired pneumonia (CAP), prevalence and risk factors for viral CAP are still debated. We evaluated the frequency of viral testing, virus prevalence, risk factors and treatment coverage with oseltamivir in patients admitted for CAP. Methods Secondary analysis of GLIMP, an international, multicenter, point-prevalence study of hospitalized adults with CAP. Testing frequency, prevalence of viral CAP and treatment with oseltamivir were assessed among patients who underwent a viral swab. Univariate and multivariate analysis was used to evaluate risk factors. Results 553 (14.9%) patients with CAP underwent nasal swab. Viral CA…

PNEUMONIAMaleMultivariate analysisInternationalityPCV13 pneumococcal conjugate vaccineDatabases FactualHospitalized patientsmedicine.medical_treatmentvirusesCAD coronary artery diseaseTesting030204 cardiovascular system & hematologyMRSA methicillin resistant Staphylococcus aureusPneumònia adquirida a la comunitatRT-PCR reverse transcriptase polymerase chain reactionchemistry.chemical_compound0302 clinical medicineCommunity-acquired pneumoniaTaverne80 and overCommunity-Acquired InfectionViral030212 general & internal medicineProspective StudiesAged 80 and overRIDT rapid influenza diagnostic testCAP community-acquired pneumoniaRSV Respiratory Syncytial virusMiddle AgedICU intensive care unitCommunity-Acquired InfectionsHospitalizationNasal SwabInfectious diseasesFemaleViral swabHumanOseltamivirmedicine.medical_specialtyLogistic ModelCommunity-acquired pneumoniaViral pneumoniaCommunity acquired pneumonia; Influenza; Oseltamivir; Testing; Viral pneumonia; Viral swab; Aged; Aged 80 and over; Antiviral Agents; Community-Acquired Infections; Cross-Sectional Studies; Databases Factual; Female; Hospitalization; Humans; Influenza Human; Internationality; Logistic Models; Male; Medication Adherence; Middle Aged; Oseltamivir; Pneumonia Viral; Prospective StudiesPneumonia ViralAdmissionSettore MED/10 - Malattie Dell'Apparato RespiratorioInfluenzavirusAntiviral AgentsVirusArticleMedication AdherenceHMPV human MetapneumovirusDatabases03 medical and health sciencesLRTI lower respiratory tract infectionOseltamivirInternal medicineInfluenza HumanInternal MedicinemedicineInfluenza virusesHumansHIV Human Immunodeficiency virusPPSV23 pneumococcal polysaccharide vaccineIn patientFactualAgedMechanical ventilationAntiviral AgentCross-Sectional Studiebusiness.industryFEV1 forced expiratory volume in one secondGLIMP global initiative for methicillin-resistant Staphylococcus aureus pneumoniaESBL extended-spectrum beta-lactamasesPneumoniamedicine.diseaseInfluenzaCommunity acquired pneumoniaCI confidence intervalOR odds ratioCross-Sectional StudiesLogistic ModelschemistryCOPD chronic obstructive pulmonary diseasebusinessCommunity acquired pneumonia ; Influenza ; Oseltamivir ; Testing ; Viral pneumonia ; Viral swab
researchProduct

The occurrence of extended-spectrum β-lactamase producing Shigella spp. in Tehran, Iran

2013

Background and Objectives: The emergence of extended-spectrum β-lactamase (ESBL)-producing Shigella spp. is of increasing clinical concern specially in children worldwide. The aim of this study was to investigate the occurrence of extended-spectrum β-lactamase producing Shigella spp. in Tehran, Iran. Materials and Methods: The study included all Shigella isolates recovered from pediatric patients aged less than 12 years admitted to a major pediatric hospital in Tehran, Iran, from 2008 to 2010. Bacterial identification, antimicrobial susceptibility testing, extended spectrum β-lactamases (ESBLs) screening and confirmatory tests were performed according to the standard guidelines. Conjugal tr…

Settore MED/07 - Microbiologia E Microbiologia ClinicaESBLsAntibiotic resistancelcsh:QR1-502ESBLs Shigella spp Antibiotic resistancebacteriaOriginal Articlebiochemical phenomena metabolism and nutritionSettore MED/42 - Igiene Generale E Applicatabacterial infections and mycosesShigella spplcsh:Microbiology
researchProduct

Détection ampérométrique d'Escherichia coli (totaux et producteurs de beta-lactamase à spectre étendu (BLSE) et d'Enterococcus spp. dans les systèmes…

2017

Treated wastewaters discharged from wastewater treatment plants (WWTP) and livestock effluents are the main sources of contamination of aquatic environments and of agricultural soils by human and animal fecal micro-organisms. Contaminated waters, especially bathing waters, may present a sanitary risk for humans if the concentrations of fecal micro-organisms are high, thus indicating the potential presence of pathogenic and/or antibiotic resistant strains. Soils and crops also can be contaminated by these micro-organisms when treated wastewaters are used to irrigate cultivated soils. Consequently, microbiological quality controls are mandatory for bathing waters and treated wastewaters to ma…

[SDE] Environmental SciencesSTEUeaux de baignadeentérocoques intestinauxintestinal enterococciscreen-printed sensors[SDV] Life Sciences [q-bio]ampérométrieESBLBLSEamperometrycapteur sérigraphiéEscherichia coli[SDV.BV] Life Sciences [q-bio]/Vegetal Biologybathing watersWWTP
researchProduct

Prevalence of CTX-M producing E. coli in cattle and soil environment in the Burgundy region

2011

National audience

[SDV] Life Sciences [q-bio][SDE] Environmental SciencesESBL[SDV]Life Sciences [q-bio][SDE]Environmental SciencesComputingMilieux_MISCELLANEOUS
researchProduct

Control of Growth and Persistence of Listeria monocytogenes and β-Lactam-Resistant Escherichia coli by Thymol in Food Processing Settings

2020

The main objective of this study was to evaluate the efficacy of thymol in controlling environmental contamination in food processing facilities. The effect of thymol was tested as an agent to prevent planktonic and bacterial biofilm growth of twenty-five Listeria monocytogenes isolates from a variety of foods and five Escherichia coli isolates from a farm. The E. coli isolates were positive for extended spectrum &beta

esblSettore CHIM/10 - Chimica Degli Alimenti<i>escherichia coli</i>Pharmaceutical ScienceSettore BIO/19 - Microbiologia Generalemedicine.disease_causebiofilmAnalytical ChemistryPersistence (computer science)lcsh:QD241-44103 medical and health scienceschemistry.chemical_compoundMinimum inhibitory concentrationlcsh:Organic chemistryListeria monocytogenesthymolDrug DiscoveryEscherichia colimedicineFood sciencePhysical and Theoretical ChemistryEscherichia coliThymolListeria monocytogene030304 developmental biology0303 health sciences030306 microbiologyOrganic ChemistryBiofilmContaminationchemistryChemistry (miscellaneous)<i>listeria monocytogenes</i>LactamMolecular MedicineMolecules
researchProduct